DEF 14A: Corteva, Inc. Announces Details for 2024 Annual Stockholder Meeting

Corteva, Inc. releases its proxy statement outlining the agenda for the 2024 Annual Stockholder Meeting, including director elections, executive compensation approval, and a certificate of incorporation amendment.

Summary

• Corteva, Inc. has released its proxy statement for the 2024 Annual Stockholder Meeting, scheduled to be held virtually on April 26, 2024.
• The agenda includes the election of 13 directors, an advisory vote on executive compensation, ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal year 2024, and approval of an amendment to Corteva's Certificate of Incorporation.
• In 2023, Corteva returned more than $1.2 billion to stockholders through dividends and share repurchases.
• The company invested $1.5 billion in biological acquisitions to drive long-term value creation.
• Management engaged with stockholders representing approximately 40% of the company's outstanding common stock in 2023.
• The Board recommends voting FOR all director nominees, FOR the advisory resolution on executive compensation, FOR the ratification of PwC, and FOR the amendment to the Certificate of Incorporation.
• As of March 1, 2024, there were 698,880,420 shares of Corteva, Inc. common stock outstanding and entitled to vote.

Sentiment

Score: 7

Explanation: The document presents a generally positive outlook, highlighting solid performance, returns to stockholders, and strategic investments. However, it also acknowledges risks and uncertainties, preventing a higher sentiment score.

Positives

• Corteva returned over $1.2 billion to stockholders via dividends and share repurchases in 2023.
• The company invested $1.5 billion in biological acquisitions.
• Management engaged with stockholders representing approximately 40% of the company's outstanding common stock in 2023.
• The Board is committed to diversity and inclusion and supportive of board candidates from underrepresented communities.
• The company was named one of the World's Most Admired Companies for 2024 by Forbes, ranking #1 in food production.
• Corteva was named a Best Place to Work for Disability Inclusion for 2023 by the Disability Inclusion Index.

Risks

• The proxy statement includes a cautionary statement about forward-looking statements, noting that actual results could differ materially due to various risks and uncertainties.
• These risks include regulatory approvals, product development, public acceptance of biotechnology, government policies, climate change, competition, dependence on third parties, input cost volatility, geopolitical conflicts, environmental litigation, global operations, acquisitions, IT disruptions, customer debt, capital markets access, pension obligations, pandemics, intellectual property, counterfeit products, and risks related to the separation from DowDuPont.

Future Outlook

The document contains forward-looking statements regarding Corteva's financial results, growth strategy, product development, regulatory approvals, market position, capital allocation, liquidity, sustainability targets, and the anticipated benefits of acquisitions and cost savings initiatives.

Management Comments

• Our teams delivered solid performance in technology penetration, customer delivery and productivity that allowed us to continue to grow our margins, despite crop protection supply imbalances.
• The strategic and operational changes we've made over the last two years will continue to allow us to optimize our resource allocation, including returns to stockholders, as well as investment in our research capabilities, to drive the long-term value creation for our stockholders and customers.

Industry Context

Corteva is positioned as a pure-play agriculture company focused on providing innovative solutions to farmers and contributing to a sustainable global agricultural system, leveraging its global scale and comprehensive routes to market.

Comparison to Industry Standards

• Corteva compares its non-employee director compensation programs to a peer group including companies like 3M, DuPont, International Flavors & Fragrances, Nutrien, and Zoetis.
• The company targets the median compensation of this peer group for all director compensation elements.

Corporate Governance

Stakeholder Impact

• The company's performance and decisions impact shareholders through returns, dividends, and strategic investments.
• Employees are affected by compensation programs, talent development initiatives, and inclusion, diversity, and equity practices.
• Customers benefit from innovative agricultural solutions and sustainable technologies.
• The company's supply chain practices and ethical standards impact suppliers.
• The company's financial stability and capital allocation decisions affect creditors.

Next Steps

• Stockholders are encouraged to vote on the agenda items before the meeting.
• The Board and management will consider the outcome of the advisory vote on executive compensation when making future compensation decisions.
• The Audit Committee will consider whether to select another independent registered public accounting firm if the selection of PwC is not ratified.

Key Dates

Keywords

proxy statement, annual meeting, directors, executive compensation, PricewaterhouseCoopers, certificate of incorporation, stockholders, corporate governance, sustainability, risk management, Corteva